The recent progress on clinical control for Middle East respiratory syndrome

CHEN Sheng-Sen, CHEN Ming-Quan

Journal of Microbes and Infections ›› 2015, Vol. 10 ›› Issue (4) : 208-214.

PDF(686 KB)
Welcome to visit Journal of Microbes and Infections, March 14, 2025
PDF(686 KB)
Journal of Microbes and Infections ›› 2015, Vol. 10 ›› Issue (4) : 208-214.
Invited paper

The recent progress on clinical control for Middle East respiratory syndrome

  • CHEN Sheng-Sen, CHEN Ming-Quan
Author information +
History +

Abstract

Middle East respiratory syndrome (MERS) is caused by MERS coronavirus (MERS­-CoV). Most people with confirmed MERS-­CoV infection develop to severe acute respiratory syndrome, and the severe patients may progress to kidney failure resulting in death. MERS was first reported in Saudi Arabia in 2012. So far, all the cases have been linked to over 20 countries in and near the Arabian Peninsula, which poses a great threat to global public health. Here the research progress on MERS clinical control is summarized.

Key words

Middle East respiratory syndrome / Middle East respiratory syndrome coronavirus / Clinical feature / Antiviral agent / Prevention and control

Cite this article

Download Citations
CHEN Sheng-Sen, CHEN Ming-Quan. The recent progress on clinical control for Middle East respiratory syndrome[J]. Journal of Microbes and Infections. 2015, 10(4): 208-214
PDF(686 KB)

Accesses

Citation

Detail

Sections
Recommended

/